null

SMILES: FC(F)(F)c1cc(Oc2ccccc2)ccc1-n1c2ccnc3sc(C(=O)N[C@@H]4CCCN(C4)C(=O)C=C)c([nH]c1=O)c23

InChI Key:

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 3 hits for monomerid = 467625   

Target/Host (Institution)	Ligand	Target/Host Links	Ligand Links	Trg + Lig Links	Ki nM	ΔG° kcal/mole	IC50 nM	Kd nM	EC50/IC50 nM	koff s-1	kon M-1s-1	pH	Temp °C
Tyrosine-protein kinase BTK (Homo sapiens (Human))	BDBM467625 ((R)-N-(1-Acryloylpiperidin-3-yl)-4-oxo-5-(4-phenox...) Show SMILES FC(F)(F)c1cc(Oc2ccccc2)ccc1-n1c2ccnc3sc(C(=O)N[C@@H]4CCCN(C4)C(=O)C=C)c([nH]c1=O)c23 |r,wD:28.29,(-2.3,6.55,;-1.91,5.06,;-.42,5.46,;-1.14,6.39,;-2.99,3.97,;-4.33,4.74,;-5.66,3.97,;-7,4.74,;-8.33,3.97,;-9.66,4.74,;-11,3.97,;-11,2.43,;-9.66,1.66,;-8.33,2.43,;-5.66,2.43,;-4.33,1.66,;-2.99,2.43,;-1.66,1.66,;-1.66,.12,;-2.99,-.65,;-2.99,-2.19,;-1.66,-2.96,;-.33,-2.19,;1.01,-2.94,;1.78,-1.21,;3.3,-1.21,;4.07,.12,;4.07,-2.55,;5.61,-2.55,;6.38,-1.21,;7.92,-1.21,;8.69,-2.55,;7.92,-3.88,;6.38,-3.88,;8.69,-5.21,;7.92,-6.55,;10.23,-5.21,;11,-3.88,;1.01,.12,;1.01,1.66,;-.33,2.43,;-.33,3.97,;-.33,-.65,)| Show InChI	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	Article PubMed	1.85E+3	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
TBA					Assay Description Covalent inhibition of recombinant human GST-tagged BTK (2 to 659 end residues) expressed in baculovirus expression system assessed as inhibition con...				Citation and Details Article DOI: 10.1021/acsmedchemlett.1c00044 BindingDB Entry DOI: 10.7270/Q25D8WM5
					More data for this Ligand-Target Pair
Tyrosine-protein kinase BTK [386-659] (Homo sapiens (Human))	BDBM467625 ((R)-N-(1-Acryloylpiperidin-3-yl)-4-oxo-5-(4-phenox...) Show SMILES FC(F)(F)c1cc(Oc2ccccc2)ccc1-n1c2ccnc3sc(C(=O)N[C@@H]4CCCN(C4)C(=O)C=C)c([nH]c1=O)c23 |r,wD:28.29,(-2.3,6.55,;-1.91,5.06,;-.42,5.46,;-1.14,6.39,;-2.99,3.97,;-4.33,4.74,;-5.66,3.97,;-7,4.74,;-8.33,3.97,;-9.66,4.74,;-11,3.97,;-11,2.43,;-9.66,1.66,;-8.33,2.43,;-5.66,2.43,;-4.33,1.66,;-2.99,2.43,;-1.66,1.66,;-1.66,.12,;-2.99,-.65,;-2.99,-2.19,;-1.66,-2.96,;-.33,-2.19,;1.01,-2.94,;1.78,-1.21,;3.3,-1.21,;4.07,.12,;4.07,-2.55,;5.61,-2.55,;6.38,-1.21,;7.92,-1.21,;8.69,-2.55,;7.92,-3.88,;6.38,-3.88,;8.69,-5.21,;7.92,-6.55,;10.23,-5.21,;11,-3.88,;1.01,.12,;1.01,1.66,;-.33,2.43,;-.33,3.97,;-.33,-.65,)| Show InChI	PDB UniProtKB/SwissProt GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	631	n/a	n/a	n/a	n/a	n/a	n/a
Janssen Pharmaceutica NV US Patent					Assay Description A BTK kinase lanthascreen binding assay monitors compound binding to unphosphorylated-BTK kinase domain (UP-BTK), by competing with a fluorescent lab...				US Patent US10822348 (2020) BindingDB Entry DOI: 10.7270/Q22V2K6B
					More data for this Ligand-Target Pair
Tyrosine-protein kinase BTK (Homo sapiens (Human))	BDBM467625 ((R)-N-(1-Acryloylpiperidin-3-yl)-4-oxo-5-(4-phenox...) Show SMILES FC(F)(F)c1cc(Oc2ccccc2)ccc1-n1c2ccnc3sc(C(=O)N[C@@H]4CCCN(C4)C(=O)C=C)c([nH]c1=O)c23 |r,wD:28.29,(-2.3,6.55,;-1.91,5.06,;-.42,5.46,;-1.14,6.39,;-2.99,3.97,;-4.33,4.74,;-5.66,3.97,;-7,4.74,;-8.33,3.97,;-9.66,4.74,;-11,3.97,;-11,2.43,;-9.66,1.66,;-8.33,2.43,;-5.66,2.43,;-4.33,1.66,;-2.99,2.43,;-1.66,1.66,;-1.66,.12,;-2.99,-.65,;-2.99,-2.19,;-1.66,-2.96,;-.33,-2.19,;1.01,-2.94,;1.78,-1.21,;3.3,-1.21,;4.07,.12,;4.07,-2.55,;5.61,-2.55,;6.38,-1.21,;7.92,-1.21,;8.69,-2.55,;7.92,-3.88,;6.38,-3.88,;8.69,-5.21,;7.92,-6.55,;10.23,-5.21,;11,-3.88,;1.01,.12,;1.01,1.66,;-.33,2.43,;-.33,3.97,;-.33,-.65,)| Show InChI	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	631	n/a	n/a	n/a	n/a	n/a	n/a
Janssen Pharmaceutica NV US Patent					Assay Description TBD				US Patent US10800792 (2020) BindingDB Entry DOI: 10.7270/Q2N019K7
					More data for this Ligand-Target Pair